ClinicalTrials.Veeva

Menu

Using HIV Risk Assessment Tool to Promote HIV Testing Among Men Who Have Sex With Men (online-RASSL)

N

National Center for AIDS/STD Control and Prevention, China CDC

Status

Unknown

Conditions

Social Media
HIV Infections
HIV/AIDS

Treatments

Behavioral: placebo control
Behavioral: HIV risk behavior assessment
Behavioral: HIV risk assessment and tailored suggestions

Study type

Interventional

Funder types

Other

Identifiers

NCT03320239
risk assessment

Details and patient eligibility

About

The objective of the study is to evaluate the effectiveness of a HIV risk assessment tool to promote HIV testing and to reduce high risk sexual behaviors among men who have sex with men (MSM). It hypothesizes that the social media-based HIV risk assessment tool can increase 20% HIV testing proportion during the six months follow-up period.

Enrollment

4,500 estimated patients

Sex

Male

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male at birth.
  • Having had homo-sexual behaviors (anal/oral) in the past 6 months before enrollment.
  • An age of 18 years or older.
  • Living in Beijing, China.
  • Self-reporting HIV negative or unknown.
  • Willingly participating into the baseline survey and the six months follow ups.
  • Agreeing not to share the research link to others.
  • Owning a mobile phone and having had downloaded the social networking Application Blued before enrollment.

Exclusion criteria

  • Not accepting blood sampling within the study period.
  • Reporting injecting drugs use in the past six months before enrollment.
  • Being currently involved in other HIV behavioral interventions for MSM.
  • Having a specific plan to leave from Beijing in the next 6 months.
  • Self-reporting female.
  • Other reasons the investigators deem make participation either detrimental to the participants or the study.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

4,500 participants in 3 patient groups, including a placebo group

the online-RASSL intervention group
Experimental group
Description:
HIV risk assessment and tailored suggestions, free HIV testing link
Treatment:
Behavioral: HIV risk assessment and tailored suggestions
intervention group 2
Experimental group
Description:
HIV risk behavior investigation and routine education
Treatment:
Behavioral: HIV risk behavior assessment
the control group
Placebo Comparator group
Description:
The placebo control: HIV/AIDS knowledge assessment, routine education
Treatment:
Behavioral: placebo control

Trial contacts and locations

1

Loading...

Central trial contact

Wu Z You, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems